Network pharmacology analysis identified AKT1 (serine/threonine protein kinase 1) and GAPDH as key hub genes involved in OC, with AKT1 playing a crucial role in the PI3K/Akt signaling pathway, which is often dysregulated in cancers. This evidence concerns the gene AKT1 and cancer.